Health

  • November 28, 2023

    Insurers Escape Allergy Treatment Groups' Antitrust Claims

    A Louisiana federal court has tossed antitrust claims from allergy testing and immunotherapy outfits against Blue Cross Blue Shield of Louisiana and other insurers after finding a lack of evidence showing a conspiracy to push the groups out of the market.

  • November 28, 2023

    UCLA Study Finds Calif. Teens Can't Get Plan B At Pharmacies

    Pharmacies in California are denying adolescents emergency contraception like Plan B despite a state law giving minors access to that treatment, according to a new study released by a research center at the UCLA School of Law.

  • November 28, 2023

    Baylor U. Says Caregiving Damages Aren't In Texas Law

    The Baylor University College of Medicine asked a Texas appellate court Monday to overturn a decision to award $11.2 million in damages in a malpractice suit, arguing the money was misappropriated by the jury and that it is owed a new trial.

  • November 28, 2023

    Group Says Doctor COVID-19 Disinformation Suit Isn't Moot

    The New Civil Liberties Alliance has told a California federal court that a suit over a California law punishing medical professionals for COVID-19 disinformation should move forward despite a newly enacted law repealing it because doctors still suffered damages and the state is sidestepping a potentially adverse ruling.

  • November 28, 2023

    Idaho Wants Abortion Travel Ban Reinstated Pending Appeal

    Idaho's attorney general told a federal court that while he appeals an injunction, he should be allowed to enforce a new state law making it a criminal offense to help minors travel out of the state to receive abortions.

  • November 28, 2023

    Mich. Health Dept. Asks 6th Circ. To Back Baby Blood Program

    Michigan health officials urged the Sixth Circuit Monday to reverse a ruling that dismantled its newborn blood-screening program, calling that program a "paragon of good government."

  • November 28, 2023

    Settlements Pave Way For Hundreds Of New NY Pot Stores

    Hundreds of provisionally licensed retailers whose applications were held up in litigation and five New York medical cannabis companies will be able to move forward with opening recreational marijuana stores after the state settled a pair of lawsuits this week.

  • November 28, 2023

    FCC To Ease Signing-Up For Rural Health Funding Projects

    At its December meeting, the Federal Communications Commission intends to get the ball rolling on making it easier for rural health care providers to sign up for financial help from the U.S. government and to reduce bureaucratic hurdles in the process.

  • November 28, 2023

    COVID Test Kit Fraud Case Is A Matter Of Timing, Jurors Told

    It all boils down to who knew what when, jurors in New Jersey federal court were told Tuesday regarding whether the ex-head of a struggling company exploited the COVID-19 pandemic to dupe investors or was the victim of a legitimate business deal gone bad.

  • November 28, 2023

    Advocates Worry 988 Hotline Georouting Will Get Delayed

    Mental health advocates are concerned the Federal Communications Commission hasn't set a firm deadline for 988 Suicide and Crisis Lifeline providers to set up georouting to find the location of callers instead of relying only on area codes.

  • November 28, 2023

    Texas High Court Weighs Damages For Unwanted Pregnancy

    Texas Supreme Court justices pondered the value of a healthy child Tuesday as they evaluated whether a woman can obtain damages for mental anguish after an unwanted pregnancy.

  • November 28, 2023

    Justices Urged To Wade Into Emergency Abortion Care Fight

    Anti-abortion groups and states have told the U.S. Supreme Court to reinstate an Idaho law criminalizing abortions in most circumstances while the federal government's challenge to the prohibition proceeds, arguing that the Biden administration has attempted an "end run" around the high court's decision overturning Roe v. Wade.

  • November 28, 2023

    Sanctioned Wholesaler Wants Abbott Labs Out Of Her Trust

    A medical wholesaler executive's wife is trying to stop Abbott Laboratories from reaching into her trust in order to satisfy a $33 million judgment against the pair that came after they were found to have engaged in discovery fraud.

  • November 28, 2023

    Aetna Wins State Appeal In NJ Benefits Reimbursement Row

    A New Jersey state appeals court dealt another win to Aetna Inc. on Tuesday in a multijurisdictional dispute by a woman claiming the insurer unlawfully demanded reimbursement from proceeds she obtained in her car accident lawsuit, rejecting her claims that Aetna failed to provide the proper paperwork leading to a delayed appeal.

  • November 28, 2023

    Feds Underpaid $281M In Support Costs, Ariz. Tribe Says

    The Gila River Indian Community claims the U.S. Department of Health and Human Services and the Indian Health Service shortchanged it millions of dollars in funding for carrying out health care programs, and caused it more than a quarter-billion dollars in damages over four years.

  • November 28, 2023

    Rep. Eshoo On Retiring: 'Health Care Has Been My North Star'

    Over three decades on Capitol Hill and five presidential administrations, Rep. Anna G. Eshoo has left a deep mark on American health care and the pharmaceutical industry. As she prepares to retire, the California Democrat spoke with Law360 about what sparked her interest in health care reform, the battle to pass the Affordable Care Act and what she hasn't been able to accomplish in her long career.

  • November 28, 2023

    Real Estate Rumors: Brent Saunders, JVM, Hudson Pacific

    The CEO of Bausch + Lomb is said to be the buyer of a $35.3 million home near Miami, JVM Realty has reportedly purchased a luxury apartment building near Chicago for a price rumored to exceed $30 million and Hudson Pacific Properties is said to have sold a 5.3-acre parcel in Sillicon Valley for $43.5 million.

  • November 28, 2023

    Fajr Capital-Led Consortium Paying $1B For Aster's Gulf Biz

    An Allen & Overy-advised consortium led by Dubai-based Fajr Capital has agreed to acquire 65% of hospital chain Aster DM Healthcare's Gulf Cooperation Council business for $1 billion, Fajr said Tuesday. 

  • November 28, 2023

    Sens. Question Anesthesia Co.'s 'Monopolistic' Model

    Sens. Elizabeth Warren and Richard Blumenthal have asked the CEO of U.S. Anesthesia Partners to rethink its "monopolistic business model" and its use of noncompete agreements among doctors.

  • November 28, 2023

    Texas Justices Scrutinize Standing In Suit Over Abortion Ban

    Texas Supreme Court justices on Tuesday repeatedly asked a group of patients suing the state over its abortion bans why they hadn't taken their doctors to court instead, suggesting their suit may not be the right vehicle to clarify abortion laws.

  • November 28, 2023

    Law Firm Leaders Cautiously Optimistic Heading Into 2024

    Major U.S. law firms are steadfast in their commitment to the pursuit of further growth despite ongoing economic uncertainty. Here’s what the leaders of four Leaderboard firms have to say about how the legal industry is preparing for next year.

  • November 28, 2023

    The 2023 Law360 Pulse Leaderboard

    Check out the Law360 Pulse Leaderboard to see which first-in-class firms made the list this year.

  • November 28, 2023

    Bristol Myers Strikes Up To $2.3B Avidity Cardio Partnership

    Bristol Myers Squibb has struck a research partnership with Avidity Biosciences Inc. that could see the biopharmaceutical giant funnel up to $2.3 billion into the discovery, development and commercialization of certain treatments for cardiovascular disease, Avidity said Tuesday. 

  • November 27, 2023

    Levi, Pomerantz Seek To Lead Insulin Pump Co. Investor Suit

    Levi & Korsinsky LLP and Pomerantz LLP want to represent a proposed class of investors in a suit alleging insulin pump maker Tandem Diabetes Care Inc. and its executives misled the public about the company's growth prospects for the year amid inflation and an uptick in competition.

  • November 27, 2023

    News Outlets Push To Toss Anti-Vax Antitrust Suit Now In DC

    The Associated Press, The Washington Post, Reuters and BBC told a D.C. federal court that the recent transfer of a lawsuit by Robert F. Kennedy Jr.'s anti-vaccine group doesn't help its claims that the news organizations colluded with social media platforms to censor rivals.

Expert Analysis

  • Employer Lessons After 2023's Successful Labor Strikes

    Author Photo

    Following recent historic strikes in the automotive, entertainment and health care industries, employers of all types can learn key insights about how unions may approach negotiations and strikes going forward, and nonunionized workplaces should anticipate a drive for increased union membership, say Lenny Feigel and Mark Neuberger at Foley & Lardner.

  • Why Criminal No-Poach Cases Can Be Deceptively Complex

    Author Photo

    Mark Rosman at Wilson Sonsini discusses the reasons many criminal no-poach cases that appear simple are actually more complicated than they seem, following several jury trial acquittals and two dismissed cases.

  • Kochava Ruling May Hint At Next Privacy Class Action Wave

    Author Photo

    The Southern District of California's recent ruling in Greenley v. Kochava and increasing complaints alleging that a consumer website is an illegal “pen register” due to the use of third-party marketing software tools foreshadow a new theory of liability for plaintiffs in privacy litigation, say attorneys at Crowell & Moring.

  • Series

    ESG Around The World: Mexico

    Author Photo

    ESG has yet to become part of the DNA of the Mexican business model, but huge strides are being made in that direction, as more stakeholders demand that companies adopt, at the least, a modicum of sustainability commitments and demonstrate how they will meet them, says Carlos Escoto at Galicia Abogados.

  • Opinion

    FDA And Companies Must Move Quickly On Drug Recalls

    Author Photo

    When a drug doesn't work as promised — whether it causes harm, like eyedrops recalled last month by the U.S. Food and Drug Administration, or is merely useless, like a widely used decongestant ingredient recently acknowledged by the agency to be ineffective — the public must be notified in a timely manner, says Vineet Dubey at Custodio & Dubey.

  • The Case For Post-Bar Clerk Training Programs At Law Firms

    Author Photo

    In today's competitive legal hiring market, an intentionally designed training program for law school graduates awaiting bar admission can be an effective way of creating a pipeline of qualified candidates, says Brent Daub at Gilson Daub.

  • 10 Takeaways From New HHS Federal Compliance Guidelines

    Author Photo

    The U.S. Department of Health and Human Services' recently issued general compliance program guidance is the first of its kind that would apply across all health care stakeholders, and signals the agency’s first step to improve and update existing compliance guidance, says Melissa Wong at Holland & Knight.

  • Ohio Voters Legalize Cannabis — What Comes Next?

    Author Photo

    This month, voters approved a citizen-initiated statute that legalizes marijuana for recreational use in Ohio, but the legalization timeline could undergo significant changes at the behest of the state's lawmakers, say Daniel Shortt and David Waxman at McGlinchey Stafford.

  • Opinion

    A Telecom Attorney's Defense Of The Chevron Doctrine

    Author Photo

    The Chevron doctrine, which requires judicial deference to federal regulators, is under attack in two U.S. Supreme Court cases — and while most telecom attorneys likely agree that the Federal Communications Commission is guilty of overrelying on it, the problem is not the doctrine itself, says Carl Northrop at Telecommunications Law Professionals.

  • 2 HHS Warnings Highlight Anti-Kickback Risks For Physicians

    Author Photo

    Two recent advisory opinions issued by the U.S. Department of Health and Human Services' Office of Inspector General involve different scenarios and rationales, but together they illustrate the OIG's focus on and disapproval of contractual joint ventures and other revenue-maximizing physician arrangements, say Robert Threlkeld and Elliott Coward at Morris Manning.

  • Attorneys Have An Ethical Duty To Protect The Judiciary

    Author Photo

    The tenor of public disagreement and debate has become increasingly hostile against judges, and though the legislative branch is trying to ameliorate this safety gap, lawyers have a moral imperative and professional requirement to stand with judges in defusing attacks against them and their rulings, says Deborah Winokur at Cozen O'Connor.

  • Cross-Market Implications In FTC's Anesthesia Complaint

    Author Photo

    The Federal Trade Commission's recent complaint against a private equity firm's acquisition of anesthesiology practices highlights the controversial issue of cross-market harm in health care provider mergers, and could provide important insights into how a court may view such theories of harm, say Christopher Lau and Dina Older Aguilar at Cornerstone Research.

  • FTC Orange Book Move Signals New Pharma Patent Scrutiny

    Author Photo

    The Federal Trade Commission's recent dispute against improper listing of drug patents in the U.S. Food and Drug Administration's Orange Book indicates heightened surveillance of the pharmaceutical industry, particularly where competition-related consequences of patent or regulatory processes are concerned, say attorneys at Fenwick.

  • AI Can Help Lawyers Overcome The Programming Barrier

    Author Photo

    Legal professionals without programming expertise can use generative artificial intelligence to harness the power of automation and other technology solutions to streamline their work, without the steep learning curve traditionally associated with coding, says George Zalepa at Greenberg Traurig.

  • Cos. Must Adapt To Calif. Immigration Data Privacy Law

    Author Photo

    California’s recently signed A.B. 947 expands the California Consumer Privacy Act and brings the state in line with other comprehensive privacy laws that address immigration status, meaning companies should make any necessary updates to their processes and disclosures, say Kate Lucente and Matt Dhaiti at DLA Piper.

Want to publish in Law360?


Submit an idea

Have a news tip?


Contact us here
Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!